The Effect Of Antihypertensive Treatment With Lisinopril and Labetalol on Baroreflex Sensitivity in Stroke - Effect Of Lisinopril and Labetalol On BRS In Stroke
- Conditions
- Stroke
- Registration Number
- EUCTR2004-004231-53-GB
- Lead Sponsor
- Royal Devon and Exeter NHS Foundation Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 23
Inclusion Criteria
Age >18 years
Clinical diagnosis of stroke
Clinical indication for antihypertensive treatment
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Contraindication to trial medication (beta blockers and ace inhibitors)
Clinical indication for beta blockers and ace inhibitors other than hypertension
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: To assess the effect of Lisinopril and Labetalol on baroreflex sensitivity in patients with cerebrovascular disease.;Secondary Objective: To assess whether any changes in baroreflex sensitivity observed are associated with changes in arterial compliance.;Primary end point(s): Change in baroreflex sensitivity
- Secondary Outcome Measures
Name Time Method